<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976907</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT04976907</nct_id>
  </id_info>
  <brief_title>Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement</brief_title>
  <acronym>MAC-VITAL</acronym>
  <official_title>Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement (MAC-VITAL): A Proof of Concept Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nuralogix Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hamilton Health Sciences Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nuralogix Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of the coronavirus disease (COVID)-19 pandemic on global healthcare systems has&#xD;
      prompted a search for novel tools to stem the tide. New digital health tools can provide&#xD;
      possible health solutions in this time of unprecedented medical crisis to mitigate the impact&#xD;
      of this pandemic. This proof of concept study will determine the feasibility and&#xD;
      effectiveness of implementing a mobile application for contactless screening and vital signs&#xD;
      measurement (MAC-VITAL) such as blood pressure (BP), heart rate (HR), respiratory rate (RR),&#xD;
      oxyhemoglobin saturation (SpO2), temperature from surgical patients peri-operatively.&#xD;
      Contactless measurement of vital signs will bridge the current gap between virtual care and&#xD;
      in-person medical assessments.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to determine whether a mobile app can accurately and reliably measure vital&#xD;
      signs without any person to person contact, and the feasibility of implementing it in a&#xD;
      peri-operative setting (e.g., during COVID-19). The validity and feasibility of the Anuraâ„¢&#xD;
      Research app will be assessed during inpatient visits in preparation for and after surgery,&#xD;
      and it will be compared with standard medical monitors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic blood pressure difference from reference measurement (mmHg)</measure>
    <time_frame>Perioperative</time_frame>
    <description>Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Diastolic blood pressure difference from reference measurement (mmHg)</measure>
    <time_frame>Perioperative</time_frame>
    <description>Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood oxygenation (SpO2) difference from reference measurement (% oxyhemoglobin saturation)</measure>
    <time_frame>Perioperative</time_frame>
    <description>Assessed against standard clinical grade instrument: Finger-based pulse oximeter (% oxyhemoglobin saturation)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse rate difference from reference measurement (beats per minute)</measure>
    <time_frame>Perioperative</time_frame>
    <description>Assessed against standard clinical grade instrument: Finger-based pulse oximeter (beats per minute)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Teperature difference from reference measurement (degrees Celsius)</measure>
    <time_frame>Perioperative</time_frame>
    <description>Assessed against standard clinical grade instrument: Forehead digital thermometer (degrees Celsius)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory rate difference from reference measurement (breaths per minute)</measure>
    <time_frame>Perioperative</time_frame>
    <description>Assessed against standard clinical grade instrument: Visual count of chest rise and fall (breaths per minute)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Obstacles to using the mobile application</measure>
    <time_frame>Perioperative</time_frame>
    <description>Characterization of obstacles to the implementation of the mobile app for perioperative vital sign measurements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection rate of clinically meaningful changes of vital signs</measure>
    <time_frame>Perioperative</time_frame>
    <description>Proportion of clinically meaningful vital sign changes detected postoperatively by the mobile application (relative to vital sign changes detected by standard clinical grade instruments).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of use survey</measure>
    <time_frame>Perioperative</time_frame>
    <description>Visual analog scale for ease of use.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction survey</measure>
    <time_frame>Perioperative</time_frame>
    <description>Visual analog scale for satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study participation</measure>
    <time_frame>Perioperative</time_frame>
    <description>Includes: Proportion of patients approached who join the study, proportion of patients who own a mobile phone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with measurement protocol</measure>
    <time_frame>Perioperative</time_frame>
    <description>Includes: Proportion of patients who comply with the measurement protocol</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Vital Signs</condition>
  <arm_group>
    <arm_group_label>Perioperative patients</arm_group_label>
    <description>Patients undergoing perioperative assessment of vital signs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Contactless vital sign information collection</intervention_name>
    <description>Collection of facial blood flow and temperature information via conventional and infrared/thermal video of the face for the purpose of estimating vital signs using machine learning-based computational models.</description>
    <arm_group_label>Perioperative patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled to undergo elective surgery under general and/or regional anesthesia.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled to undergo elective surgery under general and/or regional&#xD;
             anesthesia&#xD;
&#xD;
          -  18+ years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to consent for the study&#xD;
&#xD;
          -  Non-English speaking&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Frances Chung, MBBS, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frances Chung, MBBS, FRCPC</last_name>
    <phone>(416) 670-4253</phone>
    <email>Frances.Chung@uhn.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hamilton General Hospital (Hamilton Health Sciences)</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Russel Brown, MD</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>44890</phone_ext>
      <email>russell.brown@medportal.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Juravinski Hospital (Hamilton Health Sciences)</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8V 1C3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Russel Brown, MD</last_name>
      <phone>905-521-2100</phone>
      <phone_ext>44890</phone_ext>
      <email>russell.brown@medportal.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Matteo Parotto, MD PhD</last_name>
      <phone>(416) 340-3567</phone>
      <email>Matteo.Parotto@uhn.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital, University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Frances Chung, MBBS, FRCPC</last_name>
      <phone>(416) 670-4253</phone>
      <email>Frances.Chung@uhn.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 15, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

